Iskalni niz:
išči po
išči po
išči po
išči po
Vrsta gradiva:
Jezik:
Št. zadetkov: 3
Roadblocks of urinary EV biomarkers
Marvin Droste, Maija Puhka, Martin E. van Royen, Monica S. Y. Ng, Charles J. Blijdorp, Gloria Alvarez-Llamas, Francesc E. Borràs, Anja Büscher, Benedetta Bussolati, James W. Dear, Metka Lenassi
Pregledni znanstveni članek
Oznake: biomarkers;bladder;exosomes;extracellular vesicles;kidney;liquid biopsy;prostate;translation;urine;
Despite remarkable interest in the biomarker potential of urinary extracellular vesicles (uEVs) and the identification of numerous promising candidates, their clinical translation still presents multiple challenges. The opportunities for successful translation are obvious, yet the main roadblocks on ...
Leto: 2025 Vir: Medicinska fakulteta (UL MF)
Incidents in molecular pathology
Cleo Keppens, Yann Van Royen, Anne Brysse, Sophie Cotteret, Estrid Høgdall, Tine Plato Kuhlmann, Brendan O'Sullivan, Patrick Pauwels, Siegrid Pauwels, Mitja Rot
Izvirni znanstveni članek
Oznake: molekularna patologija;molecular pathology;
Context. Errors in laboratory medicine could compromise patient safety. Good laboratory practice includes identifying and managing nonconformities in the total test process. Varying error percentages have been described in other fields but are lacking for molecular oncology. Objectives. To gain insi ...
Leto: 2021 Vir: Digitalni repozitorij raziskovalnih organizacij Slovenije
1-year outcomes of novel balloon-expandable vs contemporary transcatheterheart valves in severe aortic stenosis
Patrick W. Serruys, Akihiro Tobe, Niels Van Royen, Ignacio J. Amat-Santos, Martin Hudec, Matjaž Bunc, Ben J. L. Van den Branden, Peep Laanmets, Daniel Unic, Bela Merkely, Simon Terseglav, Klemen Steblovnik, Miha Čerček, Luka Vitez, Miha Šušteršič, Ana Kovač, Polonca Kogoj, Ljupka Dimitrovska
Izvirni znanstveni članek
Oznake: Evolut;Myval;SAPIEN;randomizirano kontrolirana raziskava;perkutana zamenjava aortne zaklopke;randomized controlled trial;transcatheter aortic valve replacement;
Background In the LANDMARK trial, the Myval balloon-expandable transcatheter heart valve (THV) series was noninferior to the most commonly used contemporary SAPIEN and Evolut Series THVs for the 30-day early safety endpoint in participants with symptomatic severe native aortic stenosis. Objectives T ...
Leto: 2026 Vir: Digitalni repozitorij raziskovalnih organizacij Slovenije
Št. zadetkov: 3
Ključne besede:
Leto izdaje:
Avtorji:
Repozitorij:
Tipologija:
Jezik: